Mechanistically, CCL15 could promote tumor progression through the only receptor, CCR1, which is expressed by both immune cells such as monocytes41, lymphocytes46, neutrophils40, eosinophils47 and tumor cells41,48. Here, CCR1 is linked to neoplasm.